Nureca Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹349
- Today's High:
- ₹385.75
- Open Price:
- ₹381.9
- 52W Low:
- ₹294
- 52W High:
- ₹1088.1
- Prev. Close:
- ₹378.1
- Volume:
- 6222
Company Statistics
- Market Cap.:
- ₹3.42 billion
- Book Value:
- 194.879
- Revenue TTM:
- ₹1.11 billion
- Operating Margin TTM:
- -15.63%
- Gross Profit TTM:
- ₹357.92 million
- Profit Margin:
- -7.41%
- Return on Assets TTM:
- -5.11%
- Return on Equity TTM:
- -4.15%
Company Profile
Nureca Ltd had its IPO on under the ticker symbol NURECA.
The company operates in the Healthcare sector and Medical Devices industry. Nureca Ltd has a staff strength of 102 employees.
Stock update
Shares of Nureca Ltd opened at ₹381.9 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹349 - ₹385.75, and closed at ₹352.3.
This is a -6.82% slip from the previous day's closing price.
A total volume of 6,222 shares were traded at the close of the day’s session.
In the last one week, shares of Nureca Ltd have increased by +7.61%.
Nureca Ltd's Key Ratios
Nureca Ltd has a market cap of ₹3.42 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Nureca Ltd’s revenue was ₹1.11 billion with a gross profit of ₹357.92 million and an EBITDA of ₹-165120000. The EBITDA ratio measures Nureca Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Nureca Ltd’s operating margin was -15.63% while its return on assets stood at -5.11% with a return of equity of -4.15%.
In Q1, Nureca Ltd’s quarterly earnings growth was a negative -93.7% while revenue growth was a negative 48.3%.
Nureca Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹-8.25 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nureca Ltd’s profitability.
Nureca Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Nureca Ltd stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹2.07 billion
- Total Liabilities
- ₹88.83 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Nureca Ltd ended 2024 with ₹2.07 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹2.07 billion while shareholder equity stood at ₹1.95 billion.
Nureca Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹88.83 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹5.04 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Nureca Ltd’s total current assets stands at ₹1.87 billion while long-term investments were ₹0 and short-term investments were ₹1.34 billion. Its net receivables were ₹42.95 million compared to accounts payable of ₹49.90 million and inventory worth ₹344.77 million.
In 2024, Nureca Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Nureca Ltd paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹352.3
- 52-Week High
- ₹1088.1
- 52-Week Low
- ₹294
- Analyst Target Price
- ₹
Nureca Ltd stock is currently trading at ₹352.3 per share. It touched a 52-week high of ₹1088.1 and a 52-week low of ₹1088.1. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹339.17 and 200-day moving average was ₹376.63 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6298.3% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Nureca Ltd
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, connected products, glucose meters, and thermometers; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, massagers, yoga and exercise products, fitness tracking products, and dental and personal care products. It provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, blood pressure monitors, glucometer, fitness trackers, and smart weighing scales. It offers its products under the Dr Trust, Dr Physio, and Trumom brands. The company markets its products through e-commerce players, distributors, and retailers. Nureca Limited was incorporated in 2016 and is based in Chandigarh, India.